Xin Yao

PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors

Alena Gros, Paul F. Robbins, Xin Yao et al. · Journal of Clinical Investigation · 2014 · 1.1K citations · Full text

Life Sciences, Immunology, Oncology +17

Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II–Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3

Yong‐Chen Lu, Linda L. Parker, Tangying Lu et al. · Journal of Clinical Oncology · 2017 · 275 citations · Full text

Life Sciences, Immunology, Oncology +17

Levels of peripheral CD4+FoxP3+ regulatory T cells are negatively associated with clinical response to adoptive immunotherapy of human cancer

Xin Yao, Mojgan Ahmadzadeh, Yong‐Chen Lu et al. · Blood · 2012 · 199 citations · Full text

Life Sciences, Immunology, Oncology +15

Mutated PPP1R3B Is Recognized by T Cells Used To Treat a Melanoma Patient Who Experienced a Durable Complete Tumor Regression

Yong‐Chen Lu, Xin Yao, Yong F. Li et al. · The Journal of Immunology · 2013 · 153 citations · Full text

Life Sciences, Immunology, Oncology +17

Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor Antigens

Todd D. Prickett, Jessica S. Crystal, Cyrille J. Cohen et al. · Cancer Immunology Research · 2016 · 129 citations · Full text

Life Sciences, Immunology, Oncology +17